Preferred Label : linaclotide;

MeSH note : an oral guanylate cyclase C agonist linaclotide; 14 amino acid peptide for the potential treatment of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation;

CISMeF synonym : MD-1100 acetate; linaclotide acetate; linzess;

MeSH hyponym : ASP0456;

MeSH CAS label : L-tyrosine, L-cysteinyl-L-cysteinyl-L-alpha-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1- 6),(2- 10),(5- 13)-tris(disulfide);

MeSH Related Number : NSF067KU1M;

Is substance : O;

UNII : N0TXR0XR5X;

Details


Main resources

You can consult :


https://minerva-ebp.be/FR/Article/2184
2019
false
true
false
false
Belgium
adult
linaclotide
treatment outcome
defecation
randomized controlled trials as topic
double-blind method
placebos
linaclotide
critical appraisal or critical reading
chronic idiopathic constipation
constipation
chronic disease
linaclotide
peptides

---
https://www.ema.europa.eu/medicines/human/EPAR/Constella
2012
false
United Kingdom
French
English
Product containing precisely linaclotide 290 microgram/1 each conventional release oral capsule (clinical drug)
Product containing linaclotide (medicinal product)
linaclotide
drug approval
treatment outcome
administration, oral
adult
irritable bowel syndrome
constipation
aged
drug interactions
pregnancy
breast feeding
fertility
receptors, guanylate cyclase-coupled
clinical trials, phase iii as topic
randomized controlled trials as topic
abdominal pain
constipation
summary of product characteristics
package leaflet
drug evaluation
syndication feed
peptides
peptides
linaclotide
linaclotide

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.